RARECYTE, INC.
Profile
Company Names
RARECYTE, INC.
Addresses
2601 4TH AVENUE, #500, SEATTLE, WA 98121
312 DEXTER AVENUE N., SEATTLE, WA 98109
Phone Numbers
855-727-3298
425-557-1000
Entity Type:
CORPORATION
Industry:
OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$79,777,672.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-07-12
$13,174,795.00
$35,689,152.00
$22,514,357.00
Equity
4
2021-08-19
$24,046,147.00
$24,046,147.00
$0.00
Equity
3
2019-12-11
$22,156,736.00
$22,156,736.00
$0.00
Equity
2
2018-05-10
$4,999,999.00
$4,999,999.00
$0.00
Equity
1
2017-07-27
$15,399,995.00
$16,348,900.00
$948,905.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN
DANIELS
DIRECTOR
JAN
GARFINKLE
DIRECTOR
MIRABILIS MEDICA INC
| NXTHERA INC
| ACCORD BIOMATERIALS INC
| SONITUS MEDICAL INC
| SONITUS TECHNOLOGIES INC.
| MOLECULAR SYSTEMS CORP
| NEUMODX MOLECULAR, INC.
| STRATA ONCOLOGY, INC.
| NXPHASE MEDICAL, INC.
| KOYA MEDICAL, INC.
| RARECYTE, INC.
| FRANCIS MEDICAL, INC.
| REPRIEVE CARDIOVASCULAR, INC.
DAVID
KABAKOFF
DIRECTOR
TRIUS THERAPEUTICS INC
| ALLYLIX INC.
| CEBIX INC
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| LINEAGEN, INC
| HERA THERAPEUTICS INC.
| HEALTHQUEST PARTNERS II, L.P.
| NEXTCURE, INC.
| BIOTHERANOSTICS, INC.
| DAUNTLESS 1, INC.
| DAUNTLESS 2, INC.
| ANTIVA BIOSCIENCES, INC.
| BIOCLIN THERAPEUTICS, INC.
| NEURANA PHARMACEUTICALS, INC.
| RAINIER THERAPEUTICS, INC.
| RARECYTE, INC.
ANDREW
SCHWAB
DIRECTOR
TIVAMED INC
| 5AM CO-INVESTORS III, L.P.
| VIVEVE, INC.
| FLEXION THERAPEUTICS INC
| 5AM CO-INVESTORS IV, L.P.
| PURIGEN BIOSYSTEMS, INC.
| CLEAVE BIOSCIENCES, INC.
| PEAR THERAPEUTICS, INC.
| ESCIENT PHARMACEUTICALS INC
| NIDO BIOSCIENCES, INC.
| ASSAY DEPOT INC
| RARECYTE, INC.
| TMRW LIFE SCIENCES, INC.
| BEKHEALTH CORP
| HUMA.AI, INC.
| ITILITI HEALTH, INC.
| SKYE BIOSCIENCE, INC.
| RADIONETICS ONCOLOGY, INC.
| S2N HEALTH INC.
| RIDE HEALTH, INC.
ROBERT
WEISSKOFF
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
| ACCURI CYTOMETERS INC
| TRANSAVE INC
| IKANO THERAPEUTICS INC.
| ACORN CARDIOVASCULAR INC
| VIEWRAY INC
| BIOCONNECT SYSTEMS INC
| AMPHORA MEDICAL, INC.
| CARIBOU BIOSCIENCES, INC.
| IOWA APPROACH, INC.
| ZENFLOW, INC.
| TEMPEST THERAPEUTICS, INC.
| FARAPULSE, INC.
| CHECKMATE PHARMACEUTICALS, INC.
| AFFINIA THERAPEUTICS INC.
| XILIO THERAPEUTICS, INC.
| RARECYTE, INC.
| SHOUTI INC.
| BASECAMP BIO INC.
| ADELA, INC.
FRANK
WITNEY
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

